ZA905002B - A process for producing the crystal size of ondansetron hydrochloride dihydrate - Google Patents
A process for producing the crystal size of ondansetron hydrochloride dihydrateInfo
- Publication number
- ZA905002B ZA905002B ZA905002A ZA905002A ZA905002B ZA 905002 B ZA905002 B ZA 905002B ZA 905002 A ZA905002 A ZA 905002A ZA 905002 A ZA905002 A ZA 905002A ZA 905002 B ZA905002 B ZA 905002B
- Authority
- ZA
- South Africa
- Prior art keywords
- hydrochloride dihydrate
- ondansetron hydrochloride
- crystal size
- producing
- size
- Prior art date
Links
- FELGMEQIXOGIFQ-UHFFFAOYSA-N Ondansetron Chemical compound CC1=NC=CN1CC1C(=O)C(C=2C(=CC=CC=2)N2C)=C2CC1 FELGMEQIXOGIFQ-UHFFFAOYSA-N 0.000 title abstract 3
- 229960005343 ondansetron Drugs 0.000 title abstract 3
- 239000013078 crystal Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 238000002425 crystallisation Methods 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Hospice & Palliative Care (AREA)
- Animal Behavior & Ethology (AREA)
- Otolaryngology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Iron Core Of Rotating Electric Machines (AREA)
- Glass Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898914804A GB8914804D0 (en) | 1989-06-28 | 1989-06-28 | Process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA905002B true ZA905002B (en) | 1991-12-24 |
Family
ID=10659180
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA905002A ZA905002B (en) | 1989-06-28 | 1990-06-27 | A process for producing the crystal size of ondansetron hydrochloride dihydrate |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5622720A (fr) |
| EP (1) | EP0415522B1 (fr) |
| JP (1) | JP3093242B2 (fr) |
| KR (1) | KR0182789B1 (fr) |
| AT (1) | ATE110380T1 (fr) |
| AU (1) | AU637110B2 (fr) |
| CA (1) | CA2019944C (fr) |
| DE (1) | DE69011786T2 (fr) |
| DK (1) | DK0415522T3 (fr) |
| ES (1) | ES2060045T3 (fr) |
| GB (1) | GB8914804D0 (fr) |
| HK (1) | HK44495A (fr) |
| HU (1) | HU208009B (fr) |
| IE (1) | IE64715B1 (fr) |
| IL (1) | IL94888A (fr) |
| NZ (1) | NZ234267A (fr) |
| RU (1) | RU2002745C1 (fr) |
| SA (1) | SA90110025B1 (fr) |
| UA (1) | UA18249A (fr) |
| ZA (1) | ZA905002B (fr) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020115707A1 (en) * | 2001-01-11 | 2002-08-22 | Rami Lidor-Hadas | Process for preparing pure ondansetron hydrochloride dihydrate |
| MXPA04007995A (es) * | 2002-02-19 | 2004-11-26 | Teva Pharma | Desolvatacion de solvatos de hemicalcio de atorvastatina. |
| WO2003082804A1 (fr) | 2002-03-28 | 2003-10-09 | Synthon B.V. | Besylate de venlafaxine |
| US7098345B2 (en) | 2002-04-29 | 2006-08-29 | TEVA Gyógyszergyár Zárkörüen Müködö Részvénytársaság | Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-YL)methyl]-4H-carbazol-4-one |
| US20050131045A1 (en) * | 2002-04-30 | 2005-06-16 | Judith Aronhime | Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them |
| US20060083759A1 (en) * | 2002-07-17 | 2006-04-20 | Aleksander Resman | Stabilization of the profile of release of active substances from a formulation |
| CA2505990C (fr) * | 2002-11-15 | 2009-05-19 | Helsinn Healthcare S.A. | Methode pour traiter les vomissements |
| US8598219B2 (en) | 2003-01-30 | 2013-12-03 | Helsinn Healthcare Sa | Liquid pharmaceutical formulations of palonosetron |
| JO2735B1 (en) * | 2003-01-30 | 2013-09-15 | هيلسين هيلث كير أس ايه. | Liquid pharmaceutical formations of balloonosterone |
| MY143789A (en) * | 2003-02-18 | 2011-07-15 | Helsinn Healthcare Sa | Use of palonosetron treating post- operative nausea and vomiting |
| US7390503B1 (en) | 2003-08-22 | 2008-06-24 | Barr Laboratories, Inc. | Ondansetron orally disintegrating tablets |
| US20060167072A1 (en) * | 2004-01-30 | 2006-07-27 | Helsinn Healthcare Sa | Liquid pharmaceutical formulations of palonosetron |
| CA2565854A1 (fr) | 2004-05-07 | 2005-11-17 | Taro Pharmaceutical Industries Ltd. | Procede de preparation de chlorhydrate dihydrate d'ondansetron ayant une granulometrie definie |
| AU2006216696B2 (en) * | 2005-02-23 | 2011-08-18 | Teva Pharmaceutical Industries, Ltd. | Rasagiline formulations of improved content uniformity |
| UA88186C2 (ru) * | 2005-02-23 | 2009-09-25 | Тева Фармасьютикл Индастриз, Лтд. | Расагилиновые формуляции с улучшенной однородностью содержимого |
| UA97653C2 (ru) * | 2006-10-24 | 2012-03-12 | Хелсинн Хелткер С.А. | Мягкие капсулы, содержащие палоносетрона гидрохлорид, которые имеют улучшенную стабильность и биологическую доступность |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4695578A (en) * | 1984-01-25 | 1987-09-22 | Glaxo Group Limited | 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances |
| NL190373C (nl) * | 1984-01-25 | 1994-02-01 | Glaxo Group Ltd | Een 3-gesubstitueerde aminomethyl-2,3-dihydro-4(1h)-carbazolon, werkwijze ter bereiding daarvan, alsmede een farmaceutisch preparaat. |
| IE60991B1 (en) * | 1986-12-17 | 1994-09-07 | Glaxo Group Ltd | Use of ketone derivatives in the treatment of cognitive disorders |
| DK185489A (da) * | 1988-04-22 | 1989-10-23 | Duphar Int Res | Imidazolylmethyl-cycloalkanoebaaindoloner, deres fremstilling og anvendelse |
| US5344658A (en) * | 1989-06-28 | 1994-09-06 | Glaxo Group Limited | Process and composition using ondansetron |
-
1989
- 1989-06-28 GB GB898914804A patent/GB8914804D0/en active Pending
-
1990
- 1990-06-27 DK DK90307044.9T patent/DK0415522T3/da active
- 1990-06-27 ES ES90307044T patent/ES2060045T3/es not_active Expired - Lifetime
- 1990-06-27 AU AU57874/90A patent/AU637110B2/en not_active Expired
- 1990-06-27 UA UA4830462A patent/UA18249A/uk unknown
- 1990-06-27 JP JP02169655A patent/JP3093242B2/ja not_active Expired - Lifetime
- 1990-06-27 IE IE233390A patent/IE64715B1/en not_active IP Right Cessation
- 1990-06-27 ZA ZA905002A patent/ZA905002B/xx unknown
- 1990-06-27 RU SU904830462A patent/RU2002745C1/ru active
- 1990-06-27 NZ NZ234267A patent/NZ234267A/en unknown
- 1990-06-27 CA CA002019944A patent/CA2019944C/fr not_active Expired - Lifetime
- 1990-06-27 EP EP90307044A patent/EP0415522B1/fr not_active Expired - Lifetime
- 1990-06-27 KR KR1019900009540A patent/KR0182789B1/ko not_active IP Right Cessation
- 1990-06-27 IL IL9488890A patent/IL94888A/en unknown
- 1990-06-27 DE DE69011786T patent/DE69011786T2/de not_active Expired - Lifetime
- 1990-06-27 AT AT90307044T patent/ATE110380T1/de not_active IP Right Cessation
- 1990-06-27 HU HU904015A patent/HU208009B/hu unknown
- 1990-08-18 SA SA90110025A patent/SA90110025B1/ar unknown
-
1995
- 1995-03-23 HK HK44495A patent/HK44495A/xx not_active IP Right Cessation
- 1995-06-07 US US08/472,881 patent/US5622720A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| NZ234267A (en) | 1992-11-25 |
| HUT54140A (en) | 1991-01-28 |
| IL94888A0 (en) | 1991-04-15 |
| KR0182789B1 (ko) | 1999-10-15 |
| HU208009B (en) | 1993-07-28 |
| HU904015D0 (en) | 1990-12-28 |
| ATE110380T1 (de) | 1994-09-15 |
| DK0415522T3 (da) | 1994-09-19 |
| DE69011786T2 (de) | 1994-12-15 |
| IE902333A1 (en) | 1991-01-16 |
| SA90110025B1 (ar) | 2001-03-24 |
| IE64715B1 (en) | 1995-08-23 |
| AU5787490A (en) | 1991-01-03 |
| ES2060045T3 (es) | 1994-11-16 |
| US5622720A (en) | 1997-04-22 |
| EP0415522A1 (fr) | 1991-03-06 |
| KR910000709A (ko) | 1991-01-30 |
| IL94888A (en) | 1995-03-15 |
| UA18249A (uk) | 1997-12-25 |
| JP3093242B2 (ja) | 2000-10-03 |
| RU2002745C1 (ru) | 1993-11-15 |
| CA2019944C (fr) | 2000-05-09 |
| HK44495A (en) | 1995-03-31 |
| EP0415522B1 (fr) | 1994-08-24 |
| GB8914804D0 (en) | 1989-08-16 |
| JPH0395178A (ja) | 1991-04-19 |
| AU637110B2 (en) | 1993-05-20 |
| IE902333L (en) | 1990-12-28 |
| CA2019944A1 (fr) | 1990-12-28 |
| DE69011786D1 (de) | 1994-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA905002B (en) | A process for producing the crystal size of ondansetron hydrochloride dihydrate | |
| ES8300758A1 (es) | Un procedimiento para la preparacion de nuevos pirazimil-1,2,4 oxadiazol-5-onas. | |
| ZA776800B (en) | Process for the production of nitrogen-rich gases from gases,such as,for example,air,which contain at least o2 in addition to n2 | |
| CS38989A2 (en) | Method of phenoxyacetamidoderivative production | |
| DE3072012D1 (en) | Process for producing semiconductor devices, devices produced by the process, and circuits and articles including such devices | |
| EP0455582A3 (en) | Water-settable compositions, their use and process for the production of articles from such compositions | |
| CA2047256A1 (fr) | Methode pour obtenir un produit predominant dans le decabromodiphenylalcane | |
| EP0313298A3 (en) | Process for preparing modified, pregelatinized dent cornstarch and product thereof | |
| EP0312899A3 (fr) | Stabilisation de couleur | |
| HU9200771D0 (en) | Process for the production of aryl-1,2,4-triazolyn-5-on derivatives | |
| NO180531C (no) | Fremgangsmåte og anlegg for tilvirkning av råstoff-briketter for fremstilling av silisium, silisiumkarbid eller ferrosilisium | |
| HU9302717D0 (en) | New 2-spirocyclopropyl-4-acyl-cepheme compounds and process for their production | |
| EP0485612A4 (en) | Method of and device for producing nitrogen of high purity | |
| AU540927B2 (en) | Process for the obtention of carbohydrates, derived from vegetal raw material and industrial process for its derivatives | |
| HU913228D0 (en) | Process for the production of 5-aroil-2,3-dihydro-1h-pyrrholyzine-1,1-dicarboxylates | |
| KE3302A (en) | 3,1-benzoxazine-2-one derivative and process for the production of bromhexin | |
| IL100033A0 (en) | Process for the production of 4,5,6,7-tetrahydroimidazo-(4,5,ljk)(1,4)-benzodiazepine-2-(1h)-thiones as well as intermediate products | |
| JPS525700A (en) | The process for production of silicon nitride | |
| HU185927B (en) | Process for the production of 2,3-dihydro-2,2-dimethyl-7-hydroxy-benzofurane | |
| IL92948A0 (en) | Process for the production of 2,4-diamino-6-piperidinyl-pyrimidine-3-n-oxide | |
| JPS5293787A (en) | Novel process for preparation of cephem derivatives | |
| JPS5227093A (en) | Method for utilizing effectively industrial waste products containing lead | |
| HUT46366A (en) | Process for the microbiological production of 1,2-dehydro-steroids | |
| JPS5232898A (en) | Process for production of cubic boron nitride | |
| GB8922718D0 (en) | Process for spread production,apparatus for performance of the process and product obtained by the process |